Decision Diagnostics (DECN) Stock Statistics & Valuation Metrics

Decision Diagnostics has a market cap or net worth of $380.00. The enterprise value is $2.44M.

Decision Diagnostics has 380,486,150 shares outstanding. The number of shares has decreased by -2.65% in one year.

Decision Diagnostics’s return on equity (ROE) is -61.35 and return on invested capital (ROIC) is -57.78%.

The current PE Ratio of Decision Diagnostics is ―. Decision Diagnostics’s PEG ratio is -0.00038.

In the last 12 months, Decision Diagnostics had revenue of 1.98M and earned -29.67M in profits. Earnings per share was -0.11.

In the last 12 months, operating cash flow was -1.07M and capital expenditures -36.88K, giving a free cash flow of -1.11M billion.

Decision Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―

Decision Diagnostics upcoming earnings date is ―, ―.

Decision Diagnostics as a current ratio of 0.33, with Debt / Equity ratio of 604.92%

In the past 12 months, Decision Diagnostics has paid 0.00 in taxes.

Decision Diagnostics EV to EBITDA ratio is -2.99, with an EV/FCF ratio of -5.13.

Decision Diagnostics has $210.85K in cash and marketable securities with $3.24M in debt, giving a net cash position of -$3.03M billion.

Gross margin is 25.18%, with operating margin of -106.68%, and net profit margin of -1499.05%.

The average price target for Decision Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―